Literature DB >> 21126858

Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity.

Sandeep Joshi1, Utpal K Patel, Siu-Sun Yao, Vilma Castenada, April Isambert, Glenda Winson, Farooq A Chaudhry, Mark V Sherrid.   

Abstract

BACKGROUND: The ideal provocative maneuver in patients with hypertrophic cardiomyopathy (HCM) is a subject of ongoing investigation. Standing is a fundamental activity of daily life. This study examined acquisition of standing, Valsalva, and post-exercise left ventricular outflow tract gradients in HCM.
METHODS: Rest supine, standing, and post-Valsalva gradients were measured in 98 consecutive patients with HCM who were referred for outpatient echocardiography. In 53 (54%) of the 98 patients, symptom-limited treadmill exercise was also performed, with gradients measured immediately after in the supine position.
RESULTS: Fifty-six (57%) of the 98 patients had resting gradient<30 mm Hg and would thus be characterized as nonobstructive at rest. In the 98 patients, median gradients were 25 mm Hg at rest (range 0-205 mm Hg), increasing to 44 mm Hg after standing (range 0-309 mm Hg), an increase of 76%, and were again higher after Valsalva, 64 mm Hg (range 0-256 mm Hg) (P<.001). In the 53 patients who had gradient assessed after exercise, they were higher still, 100 mm Hg (range 0-256 mm Hg) (P<.001). In 29 patients (30%), standing provoked a higher gradient than Valsalva.
CONCLUSION: Although standing increased gradients by 76%, it is not as potent a provocative maneuver as Valsalva or treadmill exercise. Nevertheless, standing is recommended as a physiologic provocative maneuver. In some patients standing may guide therapy; in others, the standing and exercise gradient provide a correct appreciation of the range of physiologically experienced gradients during daily upright activity.
Copyright © 2011 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21126858     DOI: 10.1016/j.echo.2010.10.006

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  7 in total

1.  Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study.

Authors:  Damiano Magrì; Piergiuseppe Agostoni; Filippo Maria Cauti; Beatrice Musumeci; Gabriele Egidy Assenza; Carlo Nicola De Cecco; Giuseppe Muscogiuri; Antonello Maruotti; Agnese Ricotta; Erika Pagannone; Laura Marino; Daria Santini; Giulia Proietti; Andrea Serdoz; Francesco Paneni; Massimo Volpe; Camillo Autore
Journal:  Intern Emerg Med       Date:  2012-10-07       Impact factor: 3.397

Review 2.  Diagnosis and management of hypertrophic cardiomyopathy.

Authors:  Antonis Pantazis; Annina S Vischer; Maria Carrillo Perez-Tome; Silvia Castelletti
Journal:  Echo Res Pract       Date:  2015-03-11

3.  Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: A Translational Study.

Authors:  Raffaele Coppini; Cecilia Ferrantini; Josè Manuel Pioner; Lorenzo Santini; Zhinuo J Wang; Chiara Palandri; Marina Scardigli; Giulia Vitale; Leonardo Sacconi; Pierluigi Stefàno; Laura Flink; Katherine Riedy; Francesco Saverio Pavone; Elisabetta Cerbai; Corrado Poggesi; Alessandro Mugelli; Alfonso Bueno-Orovio; Iacopo Olivotto; Mark V Sherrid
Journal:  JACC Basic Transl Sci       Date:  2019-10-09

Review 4.  Cardiopulmonary Exercise Test in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.

Authors:  Adrián Bayonas-Ruiz; Francisca M Muñoz-Franco; Vicente Ferrer; Carlos Pérez-Caballero; María Sabater-Molina; María Teresa Tomé-Esteban; Bárbara Bonacasa
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

5.  Orthostatic stress echocardiography as a useful test to measure variability of transvalvular pressure gradients in aortic stenosis.

Authors:  Pawel Petkow Dimitrow; Danuta Sorysz
Journal:  Cardiovasc Ultrasound       Date:  2013-05-24       Impact factor: 2.062

6.  Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy.

Authors:  K A Blass; K E Schober; X Li; B A Scansen; J D Bonagura
Journal:  J Vet Intern Med       Date:  2014-03-05       Impact factor: 3.333

Review 7.  Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice.

Authors:  Mark V Sherrid
Journal:  Curr Cardiol Rev       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.